Dr. Dre has reportedly suffered a brain aneurysm, but is stable.
Dr. Dre has reportedly suffered a brain aneurysm, but is stable.
The Russian leader says his first call with the new US president was "business-like and frank".
The system will allow astronauts to communicate with Earth at home broadband speeds.
NEW YORK — Walmart is enlisting the help of robots to keep up with a surge in online orders. The company said Wednesday that it plans to build warehouses at its stores where self-driving robots will fetch groceries and have them ready for shoppers to pick up in an hour or less. Walmart declined to say how many of the warehouses it will build, but construction has started at stores in Lewisville, Texas; Plano, Texas; American Fork, Utah; and Bentonville, Arkansas, where Walmart’s corporate offices are based. A test site was opened more than a year ago at a store in Salem, New Hampshire. Walmart hopes the warehouses will speed up curbside pickups, where orders are brought outside to shoppers' cars. Both options became increasingly popular as virus-weary shoppers avoid going inside stores. At the start of the pandemic last year, Walmart said delivery and pickup sales grew 300%. The company said the robots won’t roam store aisles. Instead, they'll stay inside warehouses built in separate areas, either within a store or next to it. Windows will be placed at some locations so shoppers can watch the robots work. The wheeled robots carry crates of apple juice, cereal and other small goods to Walmart workers, who then bag them for shoppers. Rival Amazon uses similar technology in its warehouses, with robots bringing books, vitamins and other small items to workers to box and ship. Walmart said the robots save time since employees don’t have to walk store aisles to find items. Workers will, however, have to go into the store to pick out fresh groceries, such as meat, fish and vegetables. They’ll also have to grab TVs, vacuum cleaners and other large items that are too large for the robots to carry. _____ Follow Joseph Pisani on Twitter: @ josephpisani Joseph Pisani, The Associated Press
What's behind the soaring death and infection rates that have left 100,000 people dead?
The farmers blame Tuesday's violence on rogue protesters and say they will not call off their protest.
Two of the surviving miners have described how they made contact with rescuers while underground.
Mauricio Pochettino is determined to reunite with Dele Alli in France, while West Ham believes Chelsea’s pursuit of Declan Rice is over.
National Museum of the Royal Navy raised £600,000 in eight weeks to prevent the maps being sold abroad.
To access the call on the Internet, please log into the Capital One website at capitalone.com and follow the links from there. In addition to the press release and financials, we've included a presentation summarizing our fourth-quarter 2020 results.
SBUX earnings call for the period ending December 31, 2020.
At least two people were found dead after an hours-long SWAT team standoff in central Austin, Texas, on Tuesday night, authorities say.
The newcomer gives a devastating performance in Russell T Davies’s Aids drama. He tells Ellie Harrison about his fight against Covid scepticism, growing up queer in the Welsh Valleys, and how gay people are still suffering from Margaret Thatcher’s “hate-fuelled” propaganda
French pharmaceutical giant Sanofi said on Wednesday it had struck an agreement with Germany's BioNTech to supply the European Union with the company's vaccine developed in partnership with U.S. group Pfizer. In a press release, Sanofi, which announced last month it had to delay the launch of its own vaccine jointly developed with Britain's GlaxoSmithKline, confirmed CEO Paul Hudson's comments to newspaper Le Figaro Wednesday. "Sanofi will provide BioNTech access to its established infrastructure and expertise to produce over 125 million doses of COVID-19 vaccine in Europe", Sanofi said in statement.
Jigsaw puzzles make you smarter – and I’m living proofShould I worry about my addiction to 1,000-piece brainteasers? Not according to the scientists ‘My idea of a wild night is now crouching over a table, rummaging through a cardboard box, and going “Ooh!” when I locate the right piece.’ Photograph: Markus Spiering/Getty/EyeEm
German consumer morale fell a fourth month in a row heading into February, as extending a stricter lockdown to contain the coronavirus pandemic kept people from going shopping and splashing out, a survey showed on Wednesday. The GfK research institute said its consumer sentiment index, based on a survey of around 2,000 Germans, fell to -15.6 points from a revised -7.5 in January. Chancellor Angela Merkel and state leaders agreed last week to extend a lockdown until mid-February as Germany, once a role model for fighting the pandemic, struggles with a second wave of infections and high daily numbers of COVID-19 deaths.
Hexion Inc. ("Hexion" or the "Company") today announced that it will increase the prices of its Cardura™ Glycidyl Ester, VeoVa™ monomers and Versatic™ Acids globally for all products shipped on or after March 1, 2021, or as contract terms allow. Prices of all above mentioned products will increase by $175/MT or 150 Euro/MT. This price adjustment is primarily driven by continued increases of key raw material and logistical costs.
Vancouver, British Columbia--(Newsfile Corp. - January 27, 2021) - NetCents Technology Inc. (CSE: NC) (FSE: 26N) (OTCQB: NTTCF) ("NetCents" or the "Company"), a cryptocurrency payments company, is pleased to issue a letter to shareholders from CEO, Clayton Moore.Dear Fellow Shareholders,As I write you this letter - a letter from lockdown - 2020 was an exceptional year in exceptional times. It was an incredibly difficult year with extraordinary upheaval globally, new restrictions that none of ...
NHS Scotland Selects ServiceNow to Help Vaccinate 5.5 Million Citizens in Just 90 days
VarmX, a biotech company focusing on the development of innovative approaches for the reversal of anticoagulation, today announces the appointment of Dr. Gerard Short, MBBS, as Chief Medical Officer (CMO).
Ambu delivered organic revenue growth of 39% in Q1. The demand for single-use endoscopes is positively influenced by COVID-19. Commercial launch of aScope™ Duodeno is on track, and clinical trial has commenced. Ambu intends to raise approx. DKK 1.3bn of capital to ensure strategic and operational flexibility. Full-year outlook is maintained. “We reached revenue of one billion DKK this quarter for the first time in Ambu’s history. This milestone is the result of the dedication and focus of our organization in the midst of the COVID-19 pandemic. We’re leading the creation of the single-use endoscopy market to help hospitals take care of patients without risk of cross-contamination. Our modular R&D engine is helping us deliver technologically advanced products with an attractive economic offering across all endoscopy segments,” said CEO Juan Jose Gonzalez. “We have a promising future and are now strengthening our balance sheet to maintain flexibility as we move forward.” Highlights for the quarterComparative figures for Q1 2019/20 are stated in brackets. Revenue for Q1 was DKK 1,013m (DKK 760m) based on organic growth of 39% (14%). Sales in North America grew organically by 13%, while we saw organic growth in Europe of 79% and Rest of World of 9%.Visualization achieved organic revenue growth of 101% (24%) with strong performance across all regions. North America grew organically by 35%, Europe by 194% and Rest of World by 35%.The Visualization growth in Europe benefited from special orders for single-use bronchoscopes to the National Health Service (NHS) in England as part of their COVID-19 strategy to treat patients and build safety stocks. These orders were expected and contributed approx. 40 percentage points of the 101% organic growth for Visualization in Q1.Anaesthesia grew 5% (8%), and Patient Monitoring & Diagnostics (PMD) declined by -3% (10%). The recovery that we have seen since second half of 2019/20 continued in Q1, but especially PMD was still negatively impacted by COVID-19.The special orders to the NHS had an impact equal to 16 percentage points to the Q1 organic growth of 39%. Excluding these orders, organic growth in Q1 would have been 23%.Sales of single-use endoscopes reached 370,000 units for the quarter. Sales volumes were thus up 106% relative to last year.We secured the clearance of our aScope™ 4 Cysto in Europe and Japan and started its commercialization in these markets. As regards the aScope™ Duodeno, the commercial launch in North America and the 550-patient clinical study have started.Gross margin for the quarter was 65.4% (60.1%).Capacity costs for the quarter totaled DKK 514m (DKK 364m), corresponding to an increase of 41%. The increase reflects the investment in commercial infrastructure and innovation activities. EBIT before special items for the quarter was DKK 148m (DKK 93m) with an EBIT margin before special items of 14.6% (12.2%).Net working capital to revenue ratio was 17% (20%) by the end of the quarter based on rolling 12-month revenue.Free cash flow before acquisitions totaled DKK 2m (DKK -190m) for the quarter.Total net interest-bearing debt (NIBD) was DKK 1,701m (DKK 1,358m), corresponding to a leverage of 2.5 (2.3). The EUR 40m milestone payment associated with FDA clearance of the duodenoscope was paid in Q1.To ensure strategic and operational flexibility, Ambu intends to raise capital in an offering of new Class B shares and existing treasury shares through an accelerated bookbuilding process. The offering is expected to generate proceeds of approx. DKK 1.3bn, which will be used for general corporate purposes, including repayment of debt in order to reduce the expected leverage by end of the financial year 2020/21 from 2.7 to 1.0. Please see company announcement no. 6 for reference.The outlook for the 2020/21 financial year as announced in the annual report on 11 November 2020 is unchanged and as follows: Organic growth in the range of 17-20%. EBIT margin before special items in the range of 11-12%Sales of single-use endoscopes of 1.3-1.4 million units A conference call is held today, Wednesday 27 January 2021, at 10.00 (CET). The conference is broadcast live via www.ambu.com/webcastQ12021. The presentation can be downloaded immediately before the conference call via the same link. To ask questions in the Q&A session, please call one of the following numbers five minutes before the start of the conference: +45 3544 5577 (DK), +44 333 300 0804 (UK), +1 631 913 1422 (USA), and enter the following access code: 99186212#. CONTACTS Investors Michael Højgaard, CFO, email@example.com / +45 4030 4349Nicolai Thomsen, Director, Investor Relations, firstname.lastname@example.org / +45 2620 8047 MediaMikkel Trier Wagner, Director, Corporate Communications, email@example.com / +45 4191 0830 Attachment Q1_Company announcement no. 7 2020_21